News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Medigene AG Announces KRAS G12V as First Target for TCR-guided T Cell Engagers
Monday, December 09, 2024Medigene AG an oncology platform company focused on the research and development of T cell receptor TCRguided therapies for the treatment of cancer today announced the selection of Kirsten rat sarcoma viral oncogene homologue
Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan
Friday, December 06, 2024Teva Pharmaceutical Industries Ltd announced that it has entered into an agreement with JKI established by the fund managed and operated by JWill whereby all shares of Teva Takeda Pharma Limited and its wholly owned subsidiary Teva Takeda Yakuhin Ltd...
Saol Therapeutics Announces Submission of New Drug Application (NDA) to the U.S. FDA for SL1009
Wednesday, December 04, 2024Saol Therapeutics a privately held clinicalstage pharmaceutical company today announced the submission of a New Drug Application NDA to the US Food and Drug Administration FDA for approval of SL Sodium Dichloroacetate Oral Solution DCA for use with a...
FDA Grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan (sac-TMT) for the Treatment of Certain Patients With Previously Treated Advanced or Metastatic Nonsquamous
Wednesday, December 04, 2024Merck known as MSD outside of the United States and Canada today announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy designation to sacituzumab tirumotecan sacTMT for the treatment of patients with advanced or meta...
ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat
Tuesday, December 03, 2024Oryzon Genomics SA ISIN Code ES ORY a clinicalstage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need announced today that the Russian Patent Office has issued a Decision to grant communi...
Polyrizon Enters into GMP Manufacturing Agreement for CTM Supply of its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial
Tuesday, December 03, 2024Polyrizon Ltd a development stage biotech company specializing in the development of innovative intranasal hydrogels announces today the signing of a manufacturing agreement with Eurofins CDMO Amatsiaquitaine SAS a leading Europeanbased Good Manufact...
QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis
Thursday, November 28, 2024QIAGEN announced the launch of two new tools for designing and ordering custom solutions that can be used to support microbial analysis of bacterial fungal and viral targets These new tools enable researchers to customize their assays and panels for...
Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007
Thursday, November 28, 2024Lin BioScience a clinicalstage biopharmaceutical drug development company focused on advancing novel therapeutics targeting acute leukemia that have significant unmet medical needs today announced that its lead pipeline LBS has been granted Fast Trac...
Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies
Wednesday, November 27, 2024Roche announced that it has entered into a definitive merger agreement to acquire Poseida Therapeutics Inc a public clinicalstage biopharmaceutical company pioneering donorderived CART cell therapies Based in San Diego California Poseidas RD portfoli...
Renexxion Ireland Ltd. Announces Issuance of Fifth New U.S. Patent Covering Novel Crystal Isoform of Naronapride
Wednesday, November 27, 2024Renexxion Ireland Limited a private biopharmaceutical company dedicated to delivering innovative treatments for patients with significant unmet needs in gastrointestinal GI disorders is pleased to announce a major milestone in its intellectual proper...
